Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Drug Therapy
  4. Fast Track Articles
  5. Fast Track Article
image of Autism Spectrum Disorder: Clinical and Genetic Aspects

Abstract

Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by challenges in social communication and the presence of repetitive behaviors and restricted interests. It is acknowledged as a complex, multifactorial disorder influenced by both genetic and non- genetic factors. Recent advancements in neuroimaging studies have provided valuable insights into the observable changes in the brains of individuals with ASD. It is estimated that worldwide, about 1 in 100 children has autism. This estimate represents an average figure and reported prevalence varies substantially across studies. This review aims to explore factors influencing prevalence rates, highlighting the significant roles played by both genetic and environmental factors in the development of ASD. Furthermore, a recent study delved into the cellular structure, size, and shape of the brains of ASD individuals, revealing notable differences across various brain regions. The disparities were particularly pronounced in certain areas. While educational and behavioral treatments have traditionally been primary in managing ASD, there is growing recognition of the potential benefits of pharmacological and interventional approaches. This review strives to elucidate the diverse pathophysiological mechanisms contributing to the onset of Autism, as well as to provide insights into therapeutic interventions for the condition, emphasizing a multifaceted approach to treatment.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdth/10.2174/0115748855313794241108080912
2024-12-02
2024-12-27

  • From This Site

    /content/journals/cdth/10.2174/0115748855313794241108080912
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Zeidan J. Fombonne E. Scorah J. Ibrahim A. Durkin M.S. Saxena S. Yusuf A. Shih A. Elsabbagh M. Global prevalence of autism: A systematic review update. Autism Res. 2022 15 5 778 790 10.1002/aur.2696 35238171
    [Google Scholar]
  2. Salari N. Rasoulpoor S. Rasoulpoor S. Shohaimi S. Jafarpour S. Abdoli N. Khaledi-Paveh B. Mohammadi M. The global prevalence of autism spectrum disorder: A comprehensive systematic review and meta-analysis. Ital. J. Pediatr. 2022 48 1 112 10.1186/s13052‑022‑01310‑w 35804408
    [Google Scholar]
  3. Grossi E. Caminada E. Goffredo M. Vescovo B. Castrignano T. Piscitelli D. Valagussa G. Franceschini M. Vanzulli F. Patterns of restricted and repetitive behaviors in autism spectrum disorders: A cross-sectional video recording study. Preliminary report. Brain Sci. 2021 11 6 678 10.3390/brainsci11060678 34064245
    [Google Scholar]
  4. Leitner Y. The co-occurrence of autism and attention deficit hyperactivity disorder in children - What do we know? Front. Hum. Neurosci. 2014 8 268 10.3389/fnhum.2014.00268 24808851
    [Google Scholar]
  5. Loomes R. Hull L. Mandy W.P.L. What is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis. J. Am. Acad. Child Adolesc. Psychiatry 2017 56 6 466 474 10.1016/j.jaac.2017.03.013 28545751
    [Google Scholar]
  6. Alhowikan A.M. Elamin N.E. Aldayel S.S. AlSiddiqi S.A. Alrowais F.S. Hassan W.M. El-Ansary A. Alghamdi F.A. AL-Ayadhi L.Y. Children with autism spectrum disorder exhibit elevated physical activity and reduced sedentary behavior. Brain Sci. 2023 13 11 1575 10.3390/brainsci13111575 38002535
    [Google Scholar]
  7. Braden B.B. Pagni B.A. Monahan L. Walsh M.J.M. Dixon M.V. Delaney S. Ballard L. Ware J.E. Jr Quality of life in adults with autism spectrum disorder: influence of age, sex, and a controlled, randomized mindfulness-based stress reduction pilot intervention. Qual. Life Res. 2022 31 5 1427 1440 10.1007/s11136‑021‑03013‑x 34655389
    [Google Scholar]
  8. Kannan N. Balaji S. Anil Kumar N.V. Structural and elemental characterization of traditional Indian Siddha formulation: Thalagak karuppu. J. Ayurveda Integr. Med. 2017 8 3 184 189 10.1016/j.jaim.2016.11.005 28347563
    [Google Scholar]
  9. Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 2014 4 177 10.3389/fphar.2013.00177 24454289
    [Google Scholar]
  10. Rapoport J. Chavez A. Greenstein D. Addington A. Gogtay N. Autism spectrum disorders and childhood-onset schizophrenia: Clinical and biological contributions to a relation revisited. J. Am. Acad. Child Adolesc. Psychiatry 2009 48 1 10 18 10.1097/CHI.0b013e31818b1c63 19218893
    [Google Scholar]
  11. Ousley O. Cermak T. Autism spectrum disorder: Defining dimensions and subgroups. Curr. Dev. Disord. Rep. 2014 1 1 20 28 10.1007/s40474‑013‑0003‑1 25072016
    [Google Scholar]
  12. Dell’Osso L. Luche R.D. Gesi C. Moroni I. Carmassi C. Maj M. From asperger’s autistischen psychopathen to DSM-5 autism spectrum disorder and beyond: A subthreshold autism spectrum model. Clin. Pract. Epidemiol. Ment. Health 2016 12 1 120 131 10.2174/1745017901612010120 27867417
    [Google Scholar]
  13. Evans B. How autism became autism. Hist. Human Sci. 2013 26 3 3 31 10.1177/0952695113484320 24014081
    [Google Scholar]
  14. Allen L.R. Kelly B.B. Transforming the Workforce for Children Birth Through Age 8: A Unifying Foundation. National Academies Press 2015 4 1 620
    [Google Scholar]
  15. King B.H. Navot N. Bernier R. Webb S.J. Update on diagnostic classification in autism. Curr. Opin. Psychiatry 2014 27 2 105 109 10.1097/YCO.0000000000000040 24441420
    [Google Scholar]
  16. Zubler J.M. Wiggins L.D. Macias M.M. Whitaker T.M. Shaw J.S. Squires J.K. Pajek J.A. Wolf R.B. Slaughter K.S. Broughton A.S. Gerndt K.L. Mlodoch B.J. Lipkin P.H. Evidence-informed milestones for developmental surveillance tools. Pediatrics 2022 149 3 e2021052138 10.1542/peds.2021‑052138 35132439
    [Google Scholar]
  17. Chaste P. Leboyer M. Autism risk factors: Genes, environment, and gene-environment interactions. Dialogues Clin. Neurosci. 2012 14 3 281 292 10.31887/DCNS.2012.14.3/pchaste 23226953
    [Google Scholar]
  18. Hodges H. Fealko C. Soares N. Autism spectrum disorder: Definition, epidemiology, causes, and clinical evaluation. Transl. Pediatr. 2020 9 S1 Suppl. 1 S55 S65 10.21037/tp.2019.09.09 32206584
    [Google Scholar]
  19. Lord C. Elsabbagh M. Baird G. Veenstra-Vanderweele J. Autism spectrum disorder. Lancet 2018 392 10146 508 520 10.1016/S0140‑6736(18)31129‑2 30078460
    [Google Scholar]
  20. Gitimoghaddam M. Chichkine N. McArthur L. Sangha S.S. Symington V. Applied behavior analysis in children and youth with autism spectrum disorders: A scoping review. Perspect. Behav. Sci. 2022 45 3 521 557 10.1007/s40614‑022‑00338‑x 36249174
    [Google Scholar]
  21. Stepanova E. Dowling S. Phelps M. Findling R.L. Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents. Dialogues Clin. Neurosci. 2017 19 4 395 402 10.31887/DCNS.2017.19.4/rfindling 29398934
    [Google Scholar]
  22. Alsayouf H.A. Talo H. Biddappa M.L. De Los Reyes E. Risperidone or aripiprazole can resolve autism core signs and symptoms in young children: Case study. Children 2021 8 5 318 10.3390/children8050318 33921933
    [Google Scholar]
  23. Maras A. Schroder C.M. Malow B.A. Findling R.L. Breddy J. Nir T. Shahmoon S. Zisapel N. Gringras P. Long-term efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. J. Child Adolesc. Psychopharmacol. 2018 28 10 699 710 10.1089/cap.2018.0020 30132686
    [Google Scholar]
  24. Angelidou A. Asadi S. Alysandratos K.D. Karagkouni A. Kourembanas S. Theoharides T.C. Perinatal stress, brain inflammation and risk of autism-Review and proposal. BMC Pediatr. 2012 12 1 89 10.1186/1471‑2431‑12‑89 22747567
    [Google Scholar]
  25. Bougeard C. Picarel-Blanchot F. Schmid R. Campbell R. Buitelaar J. Prevalence of autism spectrum disorder and co-morbidities in children and adolescents: A systematic literature review. Front. Psychiatry 2021 12 744709 10.3389/fpsyt.2021.744709 34777048
    [Google Scholar]
  26. Baio J. Wiggins L. Christensen D.L. Maenner M.J. Daniels J. Warren Z. Kurzius-Spencer M. Zahorodny W. Robinson C. Rosenberg White T. Durkin M.S. Imm P. Nikolaou L. Yeargin-Allsopp M. Lee L-C. Harrington R. Lopez M. Fitzgerald R.T. Hewitt A. Pettygrove S. Constantino J.N. Vehorn A. Shenouda J. Hall-Lande J. Van K. Naarden Braun Dowling N.F. Prevalence of autism spectrum disorder among children aged 8 years — Autism and developmental disabilities monitoring network, 11 Sites, United States, 2014. MMWR Surveill. Summ. 2018 67 6 1 23 10.15585/mmwr.ss6706a1 29701730
    [Google Scholar]
  27. Jones S.C. Akram M. Gordon C.S. Murphy N. Sharkie F. Autism in Australia: Community knowledge and autistic people’s experiences. J. Autism Dev. Disord. 2021 51 10 3677 3689 10.1007/s10803‑020‑04819‑3 33389303
    [Google Scholar]
  28. Evans K. Whitehouse A.J.O. D’Arcy E. Hayden-Evans M. Wallace K. Kuzminski R. Thorpe R. Girdler S. Milbourn B. Bölte S. Chamberlain A. Perceived support needs of school-aged young people on the autism spectrum and their caregivers. Int. J. Environ. Res. Public Health 2022 19 23 15605 10.3390/ijerph192315605 36497683
    [Google Scholar]
  29. Wang J. Ma B. Wang J. Zhang Z. Chen O. Global prevalence of autism spectrum disorder and its gastrointestinal symptoms: A systematic review and meta-analysis. Front. Psychiatry 2022 13 963102 10.3389/fpsyt.2022.963102 36081466
    [Google Scholar]
  30. Sauce B. Matzel L.D. The causes of variation in learning and behavior: Why individual differences matter. Front. Psychol. 2013 4 395 10.3389/fpsyg.2013.00395 23847569
    [Google Scholar]
  31. Matos M.B. Bara T.S. Cordeiro M.L. Autism spectrum disorder diagnoses: A comparison of countries with different income levels. Clin. Epidemiol. 2022 14 959 969 10.2147/CLEP.S373186 35992506
    [Google Scholar]
  32. Maenner M.J. Warren Z. Williams A.R. Amoakohene E. Bakian A.V. Bilder D.A. Durkin M.S. Fitzgerald R.T. Furnier S.M. Hughes M.M. Ladd-Acosta C.M. McArthur D. Pas E.T. Salinas A. Vehorn A. Williams S. Esler A. Grzybowski A. Hall-Lande J. Nguyen R.H.N. Pierce K. Zahorodny W. Hudson A. Hallas L. Mancilla K.C. Patrick M. Shenouda J. Sidwell K. DiRienzo M. Gutierrez J. Spivey M.H. Lopez M. Pettygrove S. Schwenk Y.D. Washington A. Shaw K.A. Prevalence and characteristics of autism spectrum disorder among children aged 8 years — autism and developmental disabilities monitoring network, 11 Sites, United States, 2020. MMWR Surveill. Summ. 2023 72 2 1 14 10.15585/mmwr.ss7202a1 36952288
    [Google Scholar]
  33. Faras H. Al Ateeqi N. Tidmarsh L. Autism spectrum disorders. Ann. Saudi Med. 2010 30 4 295 300 10.4103/0256‑4947.65261 20622347
    [Google Scholar]
  34. Taylor L.J. Eapen V. Maybery M.T. Midford S. Paynter J. Quarmby L. Smith T. Williams K. Whitehouse A.J.O. Diagnostic evaluation for autism spectrum disorder: A survey of health professionals in Australia. BMJ Open 2016 6 9 e012517 10.1136/bmjopen‑2016‑012517 27601502
    [Google Scholar]
  35. Talantseva O.I. Romanova R.S. Shurdova E.M. Dolgorukova T.A. Sologub P.S. Titova O.S. Kleeva D.F. Grigorenko E.L. The global prevalence of autism spectrum disorder: A three-level meta-analysis. Front. Psychiatry 2023 14 1071181 10.3389/fpsyt.2023.1071181 36846240
    [Google Scholar]
  36. Adak B. Halder S. Systematic review on prevalence for autism spectrum disorder with respect to gender and socio-economic status. JMDT 2017 3 1 133 10.4172/2471‑271X.1000133
    [Google Scholar]
  37. Kang L. Liu J. Liu Y. Liang W. Yang F. Liu M. Global, regional, and national disease burden of autism spectrum disorder among children under 5 years from 1990 to 2019: An analysis for the global burden of disease 2019 study. Asian J. Psychiatr. 2023 79 103359 10.1016/j.ajp.2022.103359 36462389
    [Google Scholar]
  38. Li Q. Li Y. Liu B. Chen Q. Xing X. Xu G. Yang W. Prevalence of autism spectrum disorder among children and adolescents in the United States from 2019 to 2020. JAMA Pediatr. 2022 176 9 943 945 10.1001/jamapediatrics.2022.1846 35789247
    [Google Scholar]
  39. Raina S.K. Chander V. Bhardwaj A.K. Kumar D. Sharma S. Kashyap V. Singh M. Bhardwaj A. Prevalence of autism spectrum disorder among Rural, Urban, and tribal children (1–10 years of age). J. Neurosci. Rural Pract. 2017 8 3 368 374 10.4103/jnrp.jnrp_329_16 28694615
    [Google Scholar]
  40. Zhao Y. Luo Y. Zhang R. Zheng X. Direct and indirect costs for families of children with autism spectrum disorder in China. Autism 2023 27 8 2337 2347 10.1177/13623613231158862 36880445
    [Google Scholar]
  41. Rydzewska E. Hughes-McCormack L.A. Gillberg C. Henderson A. MacIntyre C. Rintoul J. Cooper S.A. Age at identification, prevalence and general health of children with autism: Observational study of a whole country population. BMJ Open 2019 9 7 e025904 10.1136/bmjopen‑2018‑025904 31289063
    [Google Scholar]
  42. Rylaarsdam L. Guemez-Gamboa A. Genetic causes and modifiers of autism spectrum disorder. Front. Cell. Neurosci. 2019 13 385 10.3389/fncel.2019.00385 31481879
    [Google Scholar]
  43. Hviid A. Stellfeld M. Wohlfahrt J. Melbye M. Association between thimerosal-containing vaccine and autism. JAMA 2003 290 13 1763 1766 10.1001/jama.290.13.1763 14519711
    [Google Scholar]
  44. Francis K. Autism interventions: A critical update. Dev. Med. Child Neurol. 2005 47 7 493 499 10.1017/S0012162205000952 15991872
    [Google Scholar]
  45. Powell D. Dunlap G. Fox L. Prevention and intervention for the challenging behaviors of toddlers and preschoolers. Infants Young Child. 2006 19 1 25 35 10.1097/00001163‑200601000‑00004
    [Google Scholar]
  46. Waddington H. Reynolds J.E. Macaskill E. Curtis S. Taylor L.J. Whitehouse A.J.O. The effects of JASPER intervention for children with autism spectrum disorder: A systematic review. Autism 2021 25 8 2370 2385 10.1177/13623613211019162 34348479
    [Google Scholar]
  47. Ravaghi H. Beyranvand T. Mannion R. Alijanzadeh M. Aryankhesal A. Belorgeot V.D. Effectiveness of training and educational programs for hospital managers: A systematic review. Health Serv. Manage. Res. 2021 34 2 113 126 10.1177/0951484820971460 33143488
    [Google Scholar]
  48. Ogundele M.O. Behavioural and emotional disorders in childhood: A brief overview for paediatricians. World J. Clin. Pediatr. 2018 7 1 9 26 10.5409/wjcp.v7.i1.9 29456928
    [Google Scholar]
  49. Gomez I.N. Lai C.Y.Y. Morato-Espino P.G. Chan C.C.H. Tsang H.W.H. Behavioural and autonomic regulation of response to sensory stimuli among children: A systematic review of relationship and methodology. BioMed Res. Int. 2017 2017 1 16 10.1155/2017/2629310 29333436
    [Google Scholar]
  50. Saroca K. Sargent J. Understanding families as essential in psychiatric practice. Focus Am. Psychiatr. Publ. 2022 20 2 204 209 10.1176/appi.focus.20210035 37153130
    [Google Scholar]
  51. Crowell J.A. Keluskar J. Gorecki A. Parenting behavior and the development of children with autism spectrum disorder. Compr. Psychiatry 2019 90 21 29 10.1016/j.comppsych.2018.11.007 30658339
    [Google Scholar]
  52. Yu Y. Ozonoff S. Miller M. Assessment of autism spectrum disorder. Assessment 2024 31 1 24 41 10.1177/10731911231173089 37248660
    [Google Scholar]
  53. Chen J. Wang G. Zhang K. Wang G. Liu L. A pilot study on evaluating children with autism spectrum disorder using computer games. Comput. Human Behav. 2019 90 204 214 10.1016/j.chb.2018.08.057
    [Google Scholar]
  54. Anagnostou E. Clinical trials in autism spectrum disorder: Evidence, challenges and future directions. Curr. Opin. Neurol. 2018 31 2 119 125 10.1097/WCO.0000000000000542 29389748
    [Google Scholar]
  55. Blatt G.J. Fatemi S.H. Alterations in gabaergic biomarkers in the autism brain: Research findings and clinical implications. Anat. Rec. 2011 294 10 1646 1652 10.1002/ar.21252 21901839
    [Google Scholar]
  56. Ross A. Friedmann E. Bevans M. Thomas S. National survey of yoga practitioners: Mental and physical health benefits. Complement. Ther. Med. 2013 21 4 313 323 10.1016/j.ctim.2013.04.001 23876562
    [Google Scholar]
  57. Courchesne E. Carper R. Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA 2003 290 3 337 344 10.1001/jama.290.3.337 12865374
    [Google Scholar]
  58. Mercadante S. Villari P. Ferrera P. Porzio G. Aielli F. Verna L. Casuccio A. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine. J. Pain Symptom Manage. 2006 32 2 175 179 10.1016/j.jpainsymman.2006.01.013 16877185
    [Google Scholar]
  59. Ruggeri M. Tosetto A. Palandri F. Polverelli N. Mazzucconi M.G. Santoro C. Gaidano G. Lunghi M. Zaja F. De Stefano V. Sartori R. Fazi P. Rodeghiero F. Gruppo Italiano Malattie EMatologiche dell’Adulto (GIMEMA) Anemia and Thrombocytopenias Working Party. GIMEMA Study ITP0311 Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment‐related risk factors. J. Thromb. Haemost. 2014 12 8 1266 1273 10.1111/jth.12636 24942752
    [Google Scholar]
  60. Fakhoury M. Autistic spectrum disorders: A review of clinical features, theories and diagnosis. Int. J. Dev. Neurosci. 2015 43 1 70 77 10.1016/j.ijdevneu.2015.04.003 25862937
    [Google Scholar]
  61. Franz L. Chambers N. von Isenburg M. de Vries P.J. Autism spectrum disorder in sub‐saharan africa: A comprehensive scoping review. Autism Res. 2017 10 5 723 749 10.1002/aur.1766 28266791
    [Google Scholar]
  62. Poovizhi P. Immanuel D.J. Subramani K. Dhavamani L. Dhanapal R. M- Learning first word android application to support autistic children with their education. Second International Conference on Artificial Intelligence and Smart Energy (ICAIS), Coimbatore, India, 2022, pp. 411-417. 10.1109/ICAIS53314.2022.9742808
    [Google Scholar]
  63. Howlin P. Moss P. Adults with autism spectrum disorders. Can. J. Psychiatry 2012 57 5 275 283 10.1177/070674371205700502 22546059
    [Google Scholar]
  64. Crutel V. Lambert E. Penelaud P.F. Albarrán Severo C. Fuentes J. Rosier A. Hervás A. Marret S. Oliveira G. Parellada M. Kyaga S. Gouttefangeas S. Bertrand M. Ravel D. Falissard B. Bumetanide oral liquid formulation for the treatment of children and adolescents with autism spectrum disorder: Design of two phase III studies (SIGN trials). J. Autism Dev. Disord. 2021 51 8 2959 2972 10.1007/s10803‑020‑04709‑8 33151500
    [Google Scholar]
  65. Shukla S. Pandit V. Trojan microparticles : A composite nanoparticle delivery system. Curr. Drug Ther. 2024 19 4 413 425 10.2174/1574885518666230726142855
    [Google Scholar]
  66. Domínguez-Lucio S. Compañ-Gabucio L.M. Torres-Collado L. de la Hera M.G. Occupational therapy interventions using new technologies in children and adolescents with autism spectrum disorder: A scoping review. J. Autism Dev. Disord. 2023 53 1 332 358 10.1007/s10803‑022‑05431‑3 35048236
    [Google Scholar]
  67. Divya K.Y. Begum F. John S.E. Francis F. DIR/floor time in engaging autism: A systematic review. Iran. J. Nurs. Midwifery Res. 2023 28 2 132 138 10.4103/ijnmr.ijnmr_272_21 37332371
    [Google Scholar]
/content/journals/cdth/10.2174/0115748855313794241108080912
Loading
Autism Spectrum Disorder: Clinical and Genetic Aspects
Bentham Science Publishers ; https://doi.org/10.2174/0115748855313794241108080912
/content/journals/cdth/10.2174/0115748855313794241108080912
/content/journals/cdth/10.2174/0115748855313794241108080912
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: repetitive behaviors ; genetic factor ; pharmacological approaches ; Autism spectrum disorder ; pathophysiological mechanisms ; multifactorial disorder

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test